An Anti-angiogenic Reverse Thermal Gel as a Drug-Delivery System for Age-Related Wet Macular Degeneration

Intravitreal bevacizumab as first local treatment for uveitis-related choroidal neovascularization: long-term results

(2011) Karina Julián et al.   ACTA OPHTHALMOLOGICA

Treatment of proliferative diabetic retinopathy with anti-VEGF agents

(2011) Aysha Salam et al.   ACTA OPHTHALMOLOGICA

Ocular Complications After Anti–Vascular Endothelial Growth Factor Therapy in Medicare Patients With Age-Related Macular Degeneration

(2011) Shelley Day et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration

(2011) C. Campa et al.   CURRENT DRUG TARGETS

Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents

(2011) Chirag P. Shah et al.   OPHTHALMOLOGY

Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease

(2011) Michael Tolentino   SURVEY OF OPHTHALMOLOGY

Bevacizumab and Neovascular Age Related Macular Degeneration: Pathogenesis and Treatment

(2011) Georges M. El-Mollayess et al.   Seminars in Ophthalmology

Review of Combination Therapies for Neovascular Age-Related Macular Degeneration

(2011) Steven M. Couch et al.   Seminars in Ophthalmology

A functionalizable reverse thermal gel based on a polyurethane/PEG block copolymer

(2010) Daewon Park et al.   BIOMATERIALS

Delivery of anti-angiogenic molecular therapies for retinal disease

(2010) Owen A. Anderson et al.   DRUG DISCOVERY TODAY

Intravitreal Bevacizumab (Avastin) in the Treatment of Macular Edema Associated With Perfused Retinal Vein Occlusion

(2010) Kuo-Hsuan Hung et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Injectable Biodegradable Hydrogels

(2010) Minh Khanh Nguyen et al.   MACROMOLECULAR BIOSCIENCE

Age-related macular degeneration: Current and novel therapies

(2010) Pradeep S. Prasad et al.   MATURITAS

Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration

(2009) Thomas A Ciulla et al.   CURRENT OPINION IN OPHTHALMOLOGY

Antiangiogenic Approaches to Age-Related Macular Degeneration in the Future

(2009) Diana V. Do   OPHTHALMOLOGY

Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans

(2008) Tim U. Krohne et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Biodegradable and biocompatible thermosensitive polymer based injectable implant for controlled release of protein

(2008) Y TANG et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Biodegradable fumarate-based drug-delivery systems for ophthalmic applications

(2008) M. C. Hacker et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery

(2008) Chaoliang He et al.   JOURNAL OF CONTROLLED RELEASE

Secondary Structure Effect of Polypeptide on Reverse Thermal Gelation and Degradation of l/dl-Poly(alanine)–Poloxamer–l/dl-Poly(alanine) Copolymers

(2008) Hye Jin Oh et al.   MACROMOLECULES

Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal Neovascularization

(2008) Qi Zhu et al.   OPHTHALMOLOGY